清 爽 春 夏，欣 意 相 贈(zèng)！

購 欣博盛 ELISA 試劑盒達(dá)指-定數(shù)目，即 可獲得相應(yīng)禮品！

活動(dòng)時(shí)間：2024.04.01-2024.06.30    活動(dòng)代碼：24Q2EK

● 購 1個(gè)96T 任意指標(biāo)欣博盛生QuantiCyto® /QuikCyto® 試劑盒   

   贈(zèng) 酷睿冰尊 筆記本散熱器

● 購 2個(gè)96T 任意指標(biāo)欣博盛生QuantiCyto® /QuikCyto® 試劑盒

   贈(zèng) 小熊桌面電風(fēng)扇

● 購 3個(gè)96T 任意指標(biāo)欣博盛生QuantiCyto® /QuikCyto® 試劑盒

   贈(zèng) 蘇泊爾養(yǎng)生壺

● 購 5個(gè)96T 任意指標(biāo)欣博盛生物QuantiCyto® /QuikCyto® 試劑盒

   贈(zèng) 摩飛榨汁機(jī)

● 購 10個(gè)96T 任意指標(biāo)欣博盛生物QuantiCyto® /QuikCyto® 試劑盒

   贈(zèng) 西部數(shù)據(jù)1TB 移動(dòng)硬盤

● 2個(gè)48T可按照1個(gè)96T計(jì)算；2*96T，5*96T和10*96T的包裝，每組按照1個(gè)96T試劑盒計(jì)算；

● 欣博盛階段性統(tǒng)計(jì)并發(fā)放禮品，發(fā)放時(shí)間存在一定滯后；

● 本活動(dòng)不與同期其他活動(dòng)共享，最終解釋權(quán)歸欣博盛所有

期刊：Translational Oncology, 2023

首都醫(yī)科大學(xué)宣武醫(yī)院-張老師

使用產(chǎn)品：Human IFN-γ and TNF-α ELISA Kit

● 我用過貴公司的多種細(xì)胞因子的ELISA檢測(cè)試劑盒，包括顆粒酶B和穿孔素等。首先覺得試劑盒的質(zhì)量就很好，每次檢測(cè)后標(biāo)準(zhǔn)曲線均一性不錯(cuò)，數(shù)據(jù)的可重復(fù)性強(qiáng)。其次試劑盒使用方便，簡(jiǎn)單，說明書寫得很明確，操作起來可重復(fù)性也很好?？傊?，使用貴公司的ELISA試劑盒體驗(yàn)極-佳，接下來的科研工作如果做到ELISA實(shí)驗(yàn)，也會(huì)首-選欣博盛的產(chǎn)品。

期刊：Annals of the New York Academy of Sciences, 2023

武漢大學(xué)口腔醫(yī)院-彭老師

使用產(chǎn)品：Mouse IL-1β ELISA Kit

● 非常方便，并且說明書上的步驟也非常詳細(xì)，上手很快，反應(yīng)也比較靈敏，副孔之間以及每次重復(fù)的結(jié)果相差都不大，擬合出來的標(biāo)準(zhǔn)曲線R2值比較高，可信度也很不錯(cuò)。

期刊：Immunity, 2023

南方醫(yī)科大學(xué)-曾老師

使用產(chǎn)品：Mouse TNF-α, IL-1β, IL-6 and IL-18 ELISA Kits

● 我用過好多欣博盛ELISA試劑盒，包括鼠的IL-1β、TNF-α等，總體感覺不錯(cuò)。比起進(jìn)口試劑盒，價(jià)格要公道便宜的多；與國內(nèi)其他公司相比，應(yīng)該算是國產(chǎn)頂級(jí)梯隊(duì)的產(chǎn)品了，值得信賴。

● LV J W Y, YIN J H, et al. 2023. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment. Nature Medicine [J], 6 June 2023. (IF=82.9)

● SHI X, SUN Q, HOU Y, et al. 2023. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature [J], 22 November 2023. (IF=64.8)

● CHEN X W R, LI L, et al. 2023. Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation. Immunity [J], 14 February 2023. (IF=32.4)

● CHENG J Y J, LIU Y, et al. 2023. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment. Cell Metabolism [J], 12 May 2023. (IF=29)

● ZENG Y W R, WANG F, et al. 2023. Liberation of daidzein by gut microbial β-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice. Cell Host & Microbe [J], 25 April 2023. (IF=30.3)

● LIANG W Y Y, GONG S, et al. 2023. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host & Microbe [J], 15 May 2023. (IF=30.3)

● LIU W Z S, LI Q, et al. 2023. Lactate modulates iron metabolism by binding soluble adenylyl cyclase. Cell Metabolism [J], 21 July 2023. (IF=29)

● WANG J Z L, WU N, et al. 2023. Inhibition of Phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resistance Updates [J], 14 June 2023. (IF=24.3)

● GUO Y Z X N, SU S, et al. 2023. β-adrenoreceptor-triggered PKA activation negatively regulates the innate antiviral response. Cellular & Molecular Immunology [J], 5 January 2023. (IF=24.1)

● SHI Y S J, SUN Y, et al. 2023. A Hierarchical 3D Graft Printed with Nanoink for Functional Craniofacial Bone Restoration. Advanced Functional Materials [J], 6 June 2023. (IF=19)

● LI X L Z, WANG P, et al. 2023. Dopamine‐Integrated Nanointerface between Fibrillar Matrix and Hydrophilic Nanohydroxyapatite Regulates Immune Microenvironment to Boost Endogenous Bone Regeneration. Advanced Functional Materials [J], 17January 2023. (IF=19)

● ZHANG X Y Y, LI J, et al. 2023. Engineered Oxygen Factories Synergize with STING Agonist to Remodel Tumor Microenvironment for Cancer Immunotherapy. Advanced Functional Materials [J], 19 June 2023. (IF=19)

● ZHANG L H S, MOVAHEDI F, ET AL. 2023. Amyloid-β/Tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer’s disease mice. Nano Today [J], 20 February 2023. (IF=17.4)

● SHI X, SUN Q, HOU Y, et al. 2023. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature [J], 624: 442-450.

● ZHOU P, SHE Y, DONG N, et al. 2018. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature [J], 561: 122-126.

● SHI J, ZHAO Y, WANG K, et al. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature [J], 526: 660-665.

● XU H, YANG J, GAO W, et al. 2014. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature [J], 513: 237-241.

● ZHAO Y, YANG J, SHI J, et al. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature [J], 477: 596-600.

欣博盛生物科技有限公司